Evaluation of WO2012003387, Gilead's ASK1 inhibitors

Expert Opinion on Therapeutic Patents

Volumn 22, Issue 4, 2012, Pages 455-459

  Norman, Peter ^a  

^a NORMAN CONSULTING   (United Kingdom)

Author keywords

ASK1; ASK1 inhibitor; cardiovascular disease; inflammation; neurodegenerative disease

Indexed keywords

GS 491317; GS 548606; GS 549173; GS 557119; GS 557120; GS 557614; GS 557830; GS 557832; PROPANE; PROTEIN SERINE THREONINE KINASE INHIBITOR; UNCLASSIFIED DRUG; WO 2012003387;

BIOLOGY; DRUG POTENCY; DRUG STRUCTURE; IC 50; PATENT; PHARMACOPHORE; REVIEW;

ANIMALS; DRUG DESIGN; HUMANS; MAP KINASE KINASE KINASE 5; MOLECULAR STRUCTURE; PATENTS AS TOPIC; PROTEIN KINASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84859561027     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2012.674515     Document Type: Review

References (19)

1. Ichijo H, Nishida E, Irie K, et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997;275(5296):90-4 First report on the function of ASK1.
2. Matsukawa J, Matsuzawa A, Takeda K, Ichijo H. The ASK1-MAP kinase cascades in mammalian stress response. J Biochem 2004;136(3):261-5 Review on the cellular role of ASK1.
3. Takeda K, Matsuzawa A, Nishitoh H, Ichijo H. Roles of MAPKKK ASK1 in stress-induced cell death. Cell Struct Funct 2003;28(1):23-9 (Pubitemid 36443126)
4. Takeda K, Shimozono R, Noguchi T, et al. Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1. J Biol Chem 2007;282(10):7522-31 (Pubitemid 47093697)
5. Volynets GP, Chekanov MO, Synyugin AR, et al. Identification of 3H-naphtho[ 1,2,3-de]quinoline-2,7-diones as inhibitors of apoptosis signal-regulating kinase 1 (ASK1). J Med Chem 2011;54(8):2680-6
6. Volynets GP, Bdzhola VG, Kukharenko OP, Yarmoluk SM. Identification of ASK1 small-molecule inhibitors. Ukr Biochim J 2010;82(5):41-50
7. Wang BH, Xu GY, Ho PY, et al. Apoptosis Signal-Regulating Kinase 1 Inhibition Attenuates Cardiac Myocyte Hypertrophy and Fibroblast Collagen Synthesis Stimulated by Angiotensin II-and TGFbeta: Therapeutic Potential of ASK1 Inhibitors in Myocardial Remodelling American Heart Association 2011 [abstract 12344]
8. Merck Serono SA. Triazolopyridine Compounds And Their Use As ASK Inhibitors. WO2009027283; 2009
9. Takeda Pharmaceutical Co. Ltd. Fused Heterocyclic Compound. WO2008016131; 2008
10. Takeda Pharmaceutical Co. Ltd. Apoptosis Signal-Regulating Kinase 1 Inhibitors. WO2009123986; 2009
11. Takeda Pharmaceutical Co. Ltd. Apoptosis Signal-Regulating Kinase 1 Inhibitors. WO2010008843; 2010
12. Takeda Pharmaceutical Co. Ltd. Pyrazolo [1, 5-A] Pyrimidine Derivatives As Apoptosis Signal-Regulating Kinase 1 Inhibitors. WO2011041293; 2011
13. Takeda Pharmaceutical Co. Ltd. Apoptosis Signal-Regulating Kinase 1 Inhibitors. WO2011097079; 2011
14. Gilead Sciences, Inc. Apoptosis Signal-Regulating Kinase Inhibitors. WO2012003387; 2012
15. Gilead Sciences, Inc. Methods for identifying ASK1 inhibitors useful for preventing and/or treating cardiovascular diseases. US20070276050; 2007
16. Gilead Sciences, Inc. Apoptosis Signal-Regulating Kinase Inhibitors. WO2011008709; 2011
17. Sturchler E, Feurstein D, McDonald P, Duckett D. ASK1 and Its Role in Neurodegenerative Diseases, 219-232; in Neurodegenerative Diseases - Processes, Prevention, Protection and Monitoring Ed. Chang RCC InTech, December, 2011 Useful review on one potential indication.
18. Karaman MW, Herrgard S, Treiber DK, et al. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 2008;26(1):127-32
19. Bamborough P, Drewry D, Harper G, et al. Assessment of chemical coverage of kinome space and its implications for kinase drug discovery. J Med Chem 2008;51(24):7898-914